Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_assertion type Assertion NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_head.
- NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_assertion wasGeneratedBy ECO_0000203 NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_provenance.
- NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_assertion wasDerivedFrom befree-2016 NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_provenance.
- NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_assertion SIO_000772 15901999 NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_provenance.
- NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_assertion evidence source_evidence_literature NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_provenance.
- NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_assertion description "[The GST T1 null genotype frequency in CML patients is significantly different from that in controls (odds ratio (OR) 3.12, 95% confidence interval (CI) 1.3-7.45, P=0.008).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495538.RAmC_NNGfcPWVBUWWjZLX7v184mV4NfSItynl6lzNoJfE130_provenance.